Top Page
Healius Limited
(Sydney:HLS)
Healius Limited (HLS) vs. iShares MSCI Australia ETF (EWA)
Healius Limited Business Overview & Revenue Model
Healius Limited Financial Statement Overview
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.56B | 1.75B | 1.71B | 2.29B | 1.90B | 1.58B |
| Gross Profit | 461.90M | 1.52B | 341.70M | 779.20M | 526.50M | 511.70M |
| EBITDA | 77.80M | -298.10M | -57.80M | 734.80M | 470.40M | 300.80M |
| Net Income | -22.80M | -645.80M | -367.80M | 307.90M | 43.70M | -70.50M |
Balance Sheet | ||||||
| Total Assets | 3.07B | 2.98B | 3.65B | 4.14B | 3.78B | 4.59B |
| Cash, Cash Equivalents and Short-Term Investments | 115.40M | 60.10M | 115.30M | 81.30M | 70.10M | 137.50M |
| Total Debt | 1.40B | 1.60B | 1.77B | 1.78B | 1.44B | 1.75B |
| Total Liabilities | 2.04B | 1.94B | 2.15B | 2.22B | 1.92B | 2.66B |
| Stockholders Equity | 1.03B | 1.04B | 1.51B | 1.92B | 1.86B | 1.93B |
Cash Flow | ||||||
| Free Cash Flow | 292.70M | 173.80M | 230.30M | 480.30M | 432.00M | 307.80M |
| Operating Cash Flow | 338.50M | 237.80M | 306.40M | 573.80M | 493.30M | 380.20M |
| Investing Cash Flow | -56.50M | -63.00M | 67.30M | -401.70M | 386.90M | -121.90M |
| Financing Cash Flow | -251.40M | -259.00M | -339.70M | -163.50M | -952.10M | -233.60M |
Healius Limited Technical Analysis
Healius Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$13.27B | 23.57 | 6.86% | 3.28% | 10.15% | 6.20% | |
58 Neutral | AU$551.86M | 18.26 | 18.39% | 2.49% | 7.80% | 99.87% | |
55 Neutral | AU$284.43M | ― | -0.87% | 7.12% | 14.24% | -109.59% | |
53 Neutral | AU$942.25M | 104.12 | 1.14% | 1.99% | 7.83% | ― | |
52 Neutral | $7.50B | 0.31 | -61.87% | 2.27% | 17.10% | 1.59% | |
46 Neutral | €537.34M | ― | -4.46% | ― | -7.82% | 98.08% | |
45 Neutral | AU$86.31M | ― | -47.52% | ― | 44.61% | 16.40% |
Healius Limited Corporate Events
Healius Limited has announced a change in the substantial holding of Mitsubishi UFJ Financial Group, Inc. in its shares. The voting power of Mitsubishi UFJ Financial Group, Inc. has increased from 5.22% to 6.42%, indicating a significant shift in shareholder dynamics. This change reflects Mitsubishi UFJ Financial Group, Inc.’s growing influence within the company, which could have implications for Healius Limited’s strategic decisions and stakeholder interests.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced a change in the interests of a substantial holder, First Sentier Investors Holdings Pty Limited, which is indirectly owned by Mitsubishi UFJ Financial Group. This change involves a shift in voting power and relevant interests in the company’s securities. The update reflects the substantial holder’s increased control over voting rights and securities disposal, impacting the company’s shareholder structure and potentially influencing its strategic decisions.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced a significant change in its shareholder structure with Norges Bank, the Central Bank of Norway, becoming a substantial holder. Norges Bank now holds a 5.21% voting power in Healius Limited, with its shares managed through Citicorp Nominees Pty Limited and J.P. Morgan Nominees Australia Ltd. This development marks a notable shift in the company’s ownership landscape, potentially impacting its strategic direction and stakeholder interests.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced that Mitsubishi UFJ Financial Group, Inc. has become a substantial holder in the company, acquiring a 5.22% voting power through its relevant interests in First Sentier Investors Holdings Pty Limited and Morgan Stanley. This development signifies a significant investment by Mitsubishi UFJ Financial Group, potentially impacting Healius Limited’s market dynamics and shareholder composition, as well as indicating confidence in the company’s future prospects.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Mitsubishi UFJ Financial Group (MUFG) has announced a substantial holding in Healius Limited, with First Sentier Investors Holdings Pty Limited and its subsidiaries having significant voting power in the company. This development indicates a strategic interest by MUFG in Healius, potentially impacting the company’s governance and strategic direction, as well as influencing its market positioning.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of June 20, 2025. This change in substantial holding could impact the company’s shareholder structure and influence in the market, potentially affecting its strategic decisions and stakeholder interests.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has experienced a change in the interests of a substantial holder, as reported on June 16, 2025. The notice indicates that State Street Bank and Trust Company, along with its subsidiaries, has adjusted its relevant interest in voting securities of Healius Limited. This shift in voting power could potentially impact the company’s governance and decision-making processes, reflecting the dynamic nature of shareholder interests in the company.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced a change in the substantial holding of its shares by Australian Retirement Trust Pty Ltd, which now holds an 8.865% voting power, up from 7.814%. This increase in voting power signifies a strengthened position for the Australian Retirement Trust within Healius Limited, potentially impacting the company’s governance and strategic decisions.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited announced that Perpetual Limited and its related bodies corporate have ceased to be substantial holders in the company as of May 27, 2025. This change in shareholding could impact Healius’s market dynamics and stakeholder relationships, as substantial holders often influence company decisions and strategic directions.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced the appointment of Kylie Brown as a Company Secretary, effective 29 May 2025. This strategic appointment, alongside the continued service of Stephen Humphries and Gillian Nairn in their respective roles, reinforces Healius’s commitment to maintaining robust communication and compliance with ASX Listing Rules, potentially enhancing its operational efficiency and stakeholder confidence.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has announced a change in the interests of a substantial holder, with State Street Corporation and its subsidiaries adjusting their voting power in the company. This update reflects the dynamic nature of shareholder interests and could influence the company’s governance and decision-making processes.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.65 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
Healius Limited has experienced a change in the interests of its substantial holder, Spheria Asset Management Pty Ltd, which has decreased its voting power from 8.59% to 7.34%. This change reflects a reduction in the number of shares held by Spheria, impacting the company’s shareholder dynamics and potentially influencing future decision-making processes within Healius.
Healius Limited has announced a new dividend distribution for its shareholders, with a distribution amount of AUD 0.413 per share. The ex-date for the dividend is set for May 9, 2025, with a record date of May 12, 2025, and payment scheduled for May 23, 2025. This announcement reflects Healius Limited’s ongoing commitment to delivering value to its shareholders and may positively impact its market positioning by reinforcing investor confidence.
Healius Limited has announced a fully franked special dividend of 41.3 cents per share, amounting to approximately $300 million, with key dates set for May 2025. Additionally, the company has secured a new $300 million syndicated bank facility to replace its existing $680 million facility, aiming to be in a net cash position by the end of the fiscal year, reflecting a strategic move to optimize financial operations and maintain industry competitiveness.
Healius Limited has completed the sale of Lumus Imaging to Affinity Equity Partners for $822 million, allowing Healius to focus on its pathology strategy and streamline operations. The transaction will enable Healius to pay a special dividend and provide transitional services to Lumus Imaging for up to eighteen months, ensuring a smooth transition for both the company and its patients.
Healius Limited has announced changes to the employment terms of its CEO, Paul Anderson, transitioning his role to permanent ongoing employment and increasing his fixed annual remuneration. The CEO’s incentive arrangements for FY27 will align with other key management personnel, including short-term and long-term incentives, reflecting a strategic move to enhance leadership stability and align executive compensation with company performance goals.
Healius Limited has announced the unconditional sale of its Lumus Imaging division to Affinity Equity Partners, with the completion date set for May 1, 2025. This strategic move, following the fulfillment of all conditions including regulatory approvals, is expected to impact Healius’s operations by allowing it to focus more on its core diagnostics services, potentially enhancing its market positioning and value for stakeholders.